EFFICACY AND TOLERABILITY OF BEVACIZUMAB MONOTHERAPY IN PATIENTS WITH PREVIOUSLY TREATED RECURRENT GLIOBLASTOMA MULTIFORME (GBM)

被引：0
|
作者：
Francini, E. [1 ]
Mazzaroppi, S. [1 ]
Salvati, M. [2 ]
Caponnetto, S. [1 ]
Laera, L. [3 ]
Migali, C. [3 ]
Bianco, V. [1 ]
机构：
[1] Univ Roma La Sapienza, Policlin Umberto Hosp 1, Oncol Unit, I-00185 Rome, Italy
[2] Univ Roma La Sapienza, Policlin Umberto Hosp 1, Dept Med Surg Sci & Biotechnol, I-00185 Rome, Italy
[3] Univ Siena, Policlin Santa Maria Scotte Hosp, Dept Med Oncol, I-53100 Siena, Italy
来源：
NEURO-ONCOLOGY | 2014年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P17.32
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Radiographic evaluation of recurrent glioblastoma multiforme (GBM) in patients treated with bevacizumab and irinotecan
    Andre, J.
    Spearman, K.
    Lu, S.
    Hwang, S.
    Dorsett, L.
    Raval, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] Radiographic evaluation of recurrent glioblastoma multiforme (gbm) in patients treated with bevacizumab and irinotecan
    Andre, Jalal
    Spearman, Kenneth
    Lu, Stanley
    Raval, Sumul
    [J]. NEURO-ONCOLOGY, 2007, 9 (04) : 575 - 575
  • [3] Bevacizumab and irinotecan in patients with recurrent glioblastoma multiforme (GBM)
    Raval, Sumul N.
    Rule, Amy
    Hwang, Shirley S.
    [J]. NEURO-ONCOLOGY, 2006, 8 (04) : 482 - 482
  • [4] Bevacizumab and irinotecan in patients (pts) with recurrent glioblastoma multiforme (GBM)
    Raval, S.
    Hwang, S.
    Dorsett, L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] Bevacizumab and daily temozolomide for recurrent glioblastoma multiforme (GBM)
    Maron, R.
    Vredenburgh, J. J.
    Desjardins, A.
    Reardon, D. A.
    Quinn, J. A.
    Rich, J. N.
    Gururangan, S.
    Wagner, S. A.
    Salacz, M. E.
    Friedman, H. S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] Phase II trial of bevacizumab and erlotinib in recurrent glioblastoma multiforme (GBM)
    Sathornsumetee, Sith
    Vredenburgh, James
    Rich, Jeremy
    Desjardins, Annick
    Quinn, Jennifer
    Bota, Daniela
    Goli, Krishna
    Mathe, Alyssa
    Gururangan, Sridharan
    Friedman, Allan
    Friedman, Henry
    Reardon, David
    [J]. NEURO-ONCOLOGY, 2007, 9 (04) : 516 - 516
  • [7] Tolerability and Efficacy of Bevacizumab Monotherapy in Older Patients With Recurrent Ovarian Cancer
    Shintani, Daisuke
    Yoshida, Hiroyuki
    Yabuno, Akira
    Fujiwara, Keiichi
    [J]. IN VIVO, 2020, 34 (03): : 1451 - 1457
  • [8] A pilot study to assess the tolerability and efficacy of RAD-001 (everolimus) with gefitinib in patients with recurrent glioblastoma multiforme (GBM)
    Nguyen, Teri D.
    Lassman, Andrew B.
    Lis, Eric
    Rosen, Neal
    Shaffer, David R.
    Scher, Howard I.
    DeAngelis, Lisa M.
    Abrey, Lauren E.
    [J]. NEURO-ONCOLOGY, 2006, 8 (04) : 447 - 448
  • [9] Bevacizumab in recurrent glioblastoma multiforme
    Tayah, Tania
    Ashrafieh
    Chahine, Georges Y.
    Kamar, Francois G.
    [J]. NEUROLOGY, 2008, 70 (11) : A296 - A297
  • [10] Ischemic stroke and intracranial hemorrhage in patients with recurrent glioblastoma multiforme, treated with bevacizumab
    Auer, Timo A.
    Renovanz, Mirjam
    Marini, Federico
    Brockmann, Marc A.
    Tanyildizi, Yasemin
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2017, 133 (03) : 571 - 579
12345